Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.68% | 3.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.68% | 3.89% | |||
| Cost of Revenue | -15.15% | 14.30% | |||
| Gross Profit | -9.88% | -5.83% | |||
| SG&A Expenses | 2.98% | 9.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.02% | 10.38% | |||
| Operating Income | -1.88% | -22.38% | |||
| Income Before Tax | 22.53% | -26.03% | |||
| Income Tax Expenses | -155.51% | 130.51% | |||
| Earnings from Continuing Operations | 23.59% | -26.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.59% | -26.48% | |||
| EBIT | -1.88% | -22.38% | |||
| EBITDA | -1.32% | -43.81% | |||
| EPS Basic | 24.40% | -25.52% | |||
| Normalized Basic EPS | 24.37% | -57.36% | |||
| EPS Diluted | 24.40% | -25.52% | |||
| Normalized Diluted EPS | 24.37% | -57.36% | |||
| Average Basic Shares Outstanding | 0.98% | 0.81% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||